Home ••• Newswires by Industry • Countries • U.S. States • World Media Directory

Pharmaceutical Industry News ••• Topics • Countries • U.S. States

Aromatase Inhibitors News Monitoring

Get by Email • RSS

Published on Jun 2, 2025

ASCO 2025: AstraZeneca’s novel trial design for camizestrant pays off in breast cancer

AstraZeneca has presented results for the SERENA-6 trial at the American Society for Medical Oncology (ASMO)’s 2025 conference, held in Chicago, Illinois from 30 May to 3 June. The SERENA-6 trial compares camizestrant, an oral selective oestrogen receptor …

Source: Clinical Trials Arena - Pending
Published on Jun 2, 2025

ASCO 2025: Expert Insights on Endocrine, Cardiac, Ocular, and Dermatologic Toxicities in Breast Cancer Care

Toxicities are a common occurrence in patients with breast cancer (BC) being treated with novel therapies like endocrine therapies, targeted therapies, or immunotherapies. This can make treatment challenging as clinicians aim to treat the patient’s cancer …

Source: Pharmacy Times - Neutral
Published on 01:39 GMT

Imlunestrant Alone or With Verzenios Improved PROs in Advanced Breast Cancer

Imlunestrant alone or in combination with Verzenios (abemaciclib) improved patient-reported outcomes among those with with estrogen receptor (ER)–positive, HER2-negative advanced breast cancer who progressed after endocrine therapy. Notably, these data …

Source: Cure Today - Neutral
Published on 00:55 GMT

Breast Cancer Targeted Therapies and Guidelines, Part 2

Photo Credit: iStock.com/Anastasia Usenko This slideshow highlights some of the latest breakthroughs in breast cancer treatment, spotlighting key molecular pathways—PI3K/AKT/mTOR, RAS/RAF/MEK/ERK, JAK/STAT, and SRC—that are …

Source: Physician's Weekly - Neutral
Published on Jun 2, 2025

AstraZeneca Highlights Significant Gains Across Three Major Cancer Trials At ASCO

AstraZeneca Plc AZN on Monday released results from three Phase 3 clinical trials at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting: DESTINY-Breast09, MATTERHORN, and SERENA-6. In the DESTINY-Breast09 trial, Enhertu (trastuzumab …

Source: Benzinga - Neutral
Published on Jun 2, 2025

ASCO 25: AZ pitches upfront oral SERD use in breast cancer

AstraZeneca wants to make its oral selective oestrogen receptor degrader (SERD) drug camizestrant a go-to frontline therapy for HR-positive breast cancer, and made its case at ASCO with data from the SERENA-6 trial. The reveal of results first signposted …

Source: pharmaphorum - Neutral
Published on Jun 2, 2025

How This Pharma Titan Plans To Become An $80 Billion Company

Three new cancer drugs could help AstraZeneca (AZN) make a dent in its lofty ambition to become an $80 billion company by 2030, an executive told Investor's Business Daily. On Sunday and Monday, AstraZeneca unveiled the results of three studies in …

Source: Investor's Business Daily - Neutral
Published on Jun 2, 2025

[ASCO 2025] Anticancer giant AZ expands its therapeutic armamentarium with Camizestrant-Imfinzi

CHICAGO, Ill—By Hong Sook/ Korea Biomedical Review correspondent—AstraZeneca, the oncology leader with Enhertu, co-developed with Daiichi Sankyo, is expanding its treatment of hormone receptor (HR) breast cancer and HER2-positive gastric cancer. For …

Source: Korea Biomedical Review - Neutral
Published on Jun 2, 2025

Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options ...

Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first and only FDA-approved interchangeable denosumab biosimilars available in US Improves access for patients …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on Jun 2, 2025

Drug-defying breast cancers spotted early in blood test study

Breast cancer patients whose tumors have spread to other parts of their bodies live from scan to scan. Is their treatment working? Or will they learn their cancer is growing again? But a new study sponsored by the drug company AstraZeneca showed that there …

Source: The Spokesman-Review - Washington State - Neutral
Published on Jun 1, 2025

Ribociclib Benefit Is Sustained in HR+ Early Breast Cancer Regardless of Age, Menopausal Status

Ribociclib (Kisqali) combined with a nonsteroidal aromatase inhibitor (NSAI) demonstrated consistent benefits in invasive disease-free survival (iDFS), distant disease-free survival (DDFS), recurrence-free survival (RFS), and distant relapse-free survival …

Source: OncLive - Pending
Published on Jun 1, 2025

Camizestrant at detection of ESR1 mutation improves survival for advanced breast cancer

Add topic to email alerts Subscribe We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Key takeaways: Detection of ESR1 mutations with ctDNA before …

Source: Healio News - Neutral
Published on Jun 1, 2025

Blood test-guided treatment with AstraZeneca pill cuts breast cancer progression risk

By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance to standard therapies cut the risk of disease progression or death by half, a finding that could be …

Source: Regional Media News - Iowa - Pending
Published on Jun 1, 2025

Next-generation breast cancer drug targets tumours

Image by the US National Institutes of Health, CC 3.0 A powerful new drug for advanced breast cancer can be used to treat emerging resistance to treatment – months before tumours have a chance to grow. Results showed patients who were given the new therapy …

Source: Digital Journal - Neutral
Published on Jun 1, 2025

AstraZeneca drug could help keep a common breast cancer at bay

Too often, cancer has a way of evading treatment. Tumors that were held in check begin to spread anew, forcing doctors to try different drugs in a desperate race to keep malignant cells from multiplying. For a common type of breast cancer, this usually …

Source: BioPharma Dive - Pending
Published on Jun 1, 2025

A funding flashpoint, Pfizer’s $1B poster and AstraZeneca advertising

Funding cancer research isn't usually a political flashpoint. But as the Trump administration signals its desire to drastically cut the budget of the National Cancer Institute, the American Society of Clinical Oncology is finding itself forced to …

Source: BioPharma Dive - Pending
Published on Jun 1, 2025

Switching to Experimental Drug Following Liquid Biopsy Detection of Breast Cancer Recurrence Enhances Patient Outcomes

A groundbreaking clinical trial has recently unveiled the transformative potential of liquid biopsy technology in the management of advanced breast cancer, specifically targeting treatment-resistant mutations to extend tumor control and enhance patient …

Source: Bioengineer.org - Pending
Published on Jun 1, 2025

Switch to experimental drug after liquid biopsy detection of breast cancer recurrence improves outcomes

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, …

Source: EurekAlert! - Neutral
Published on Jun 1, 2025

Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds

By Julie Steenhuysen CHICAGO (Reuters) -Treating breast cancer patients with AstraZeneca’s experimental pill camizestrant at the first sign of resistance to standard treatments cut the risk of disease progression or death by half, a finding that could …

Source: Regional Media News - Iowa - Pending

29 days 07:31:09

Featured Releases

Got News to Share? · Submit · See All

Published on June 2, 2025 - 11:28 GMT

In-Depth Analysis Of The Global Pharma And Biotech Crm Software Market: Key Drivers, Trends, And Forecast 2025-2034

The Business Research Company's Pharma And Biotech CRM Software Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 23:30 GMT

Live from ASCO 2025 | Ascentage Pharma Presents Clinical Data on Bcl-2 Inhibitor Lisaftoclax in Venetoclax-Refractory ...

ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 2, 2025 - 23:30 GMT

Live from ASCO 2025 | Ascentage Pharma Releases Promising Clinical Data on Alrizomadlin Monotherapy and Combinations in ...

ROCKVILLE, Md. and SUZHOU, China, June 02, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest clinical …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on June 2, 2025 - 23:30 GMT

Nxera Pharma to Receive US$15 Million from Neurocrine Biosciences Following Dosing of First Patient in Phase 3 Trial of ...

Tokyo, Japan and Cambridge, UK, 3 June 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that its partner, Neurocrine Biosciences (“Neurocrine”) has dosed the first patient in its Phase 3 registrational program of NBI- …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on June 2, 2025 - 22:30 GMT

Eupraxia Pharmaceuticals Announces Voting Results from Annual General and Special Meeting of Shareholders

VICTORIA, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX) (NASDAQ: EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on June 3, 2025 - 00:55 GMT

Hawaiʻi Secures $700 Million Settlement in Pharmaceutical Lawsuit

Posted on Jun 2, 2025 in Main Governor Green and Attorney General Lopez shake hands at the press conference announcing the pharmaceutical settlement. In a significant win for the state, Governor Josh Green, M.D., and Attorney General Anne Lopez announced a …

Distribution channels: U.S. Politics
Published on June 3, 2025 - 01:00 GMT

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Avis Budget, Civitas, ...

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Avis Budget Group, Inc. (NASDAQ:CAR), …

Distribution channels: Consumer Goods, Law ...
Published on June 3, 2025 - 01:00 GMT

UROGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against UroGen Pharma Ltd....

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ:URGN) in …

Distribution channels: Consumer Goods, Law ...

Got news to share? Submit it now.

Load more pharmaceuticals news or search news using your own keywords. There are 818,467,502 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country

Pharmaceutical Industry News by U.S. State

Pharmaceutical Industry News Topics

Online News Publications

World News Report

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter

Create RSS Feed

NewsPlugin for WordPress

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire

Events

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 05/18/2025

World Media Directory

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All

Published on June 3, 2025 - 00:00 GMT

Blue Sky Scrubs Celebrates World Bicycle Day with a Wellness and Sustainability Initiative Honoring the Power of Pedals

In celebration of World Bicycle Day, Blue Sky Scrubs, is announcing an initiative promoting cardiovascular health, environmental care, and active living. AUSTIN, TX, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- In celebration of World …

Distribution channels: Consumer Goods, Culture, Society & Lifestyle ...
Published on June 3, 2025 - 00:00 GMT

Behavidence Becoming Mental Health Infrastructure Backbone for U.S., U.K., and Israeli Governments

Behavidence becomes core mental health infra for US, UK & Israel; powers early detection, suicide prevention & will soon integrate with all major EHRs. NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- ehavidence, the …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 20:35 GMT

O’Keeffe’s Summer Skin Secret Weapons

NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- This summer, ditch the hype and get serious about skincare that actually delivers. Most people just want products that work – especially during the months when skin takes center …

Distribution channels: Beauty & Hair Care, Consumer Goods ...
Published on June 2, 2025 - 20:31 GMT

Homecare Providers Challenge California Democrats to Stand Up to Newsom’s Budget at State Party Convention

Homecare Providers Challenge California Democrats to Stand Up to Newsom’s Budget at State Party Convention ANAHEIM, CA, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- MayToday, UDW/AFSCME Local 3930 members and leaders, joined by SEIU …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 19:38 GMT

Approved Senior Network® Launches New Video Series Called the Gatekeeper Tapes, for Home Care Marketing

Approved Senior Network®, a leading home care marketing and sales training agency, has released a powerful two-part video series. SAINT CHARLES, MO, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Approved Senior Network®, a leading home care …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...
Published on June 2, 2025 - 19:15 GMT

YTC Healthcare Expands Surgical Nurse Placement Services in Operating Rooms Across Canada

Addressing Surgical Staffing Crises Through Strategic Nationwide Expansion MISSISSAUGA, ONTARIO, CANADA, June 2, 2025 /⁨EINPresswire.com⁩/ -- YTC Healthcare has officially expanded its surgical nurse placement services across operating rooms in …

Distribution channels: Companies, Emergency Services ...
Published on June 2, 2025 - 19:12 GMT

Ascend, Inc. Celebrates Inaugural Year Marked by Industry Accolades and Strong Company Culture

Marking its one-year anniversary, Ascend celebrates its impactful expertise in UKG solutions, validated by industry awards and a dedicated, highly engaged team BOULDER, CO, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Ascend, Inc., a …

Distribution channels: Business & Economy, Companies ...
Published on June 2, 2025 - 18:59 GMT

Alison Bartlet Joins GS1 GDSN Board, Continuing Commport’s Legacy in Global Standards

Following CEO Dave Ralph’s retirement, Bartlet steps in to represent solution providers at the highest level of GDSN leadership. AURORA, ONTARIO, CANADA, June 2, 2025 /⁨EINPresswire.com⁩/ -- GS1, a global not-for-profit standards organization, has …

Distribution channels: Consumer Goods, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 18:48 GMT

Breakthrough Cancer Drug Makes Cancer Cells Collapse from Within — No Harm to Healthy Tissue

New drug triggers cancer cell self-destruction from the inside—obliterates tumors while leaving healthy tissue completely untouched. CAMBRIDGE, MA, UNITED STATES, May 27, 2025 /⁨EINPresswire.com⁩/ -- In a revolutionary leap for cancer treatment, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 18:25 GMT

Forte Speech & Language Therapy Releases In-Depth Report on Supporting Children's Writing Development

LOS ANGELES, CA, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Forte Speech & Language Therapy Releases In-Depth Report on Supporting Children's Writing Development Forte Speech & Language Therapy, a leading LA speech therapist …

Distribution channels: Business & Economy, Companies ...
Published on June 2, 2025 - 18:14 GMT

Why More Doctors Should Speak Spanish: NHMA 2025 Conference Tackles Language Gaps in Health Care

NHMA’s 2025 Conference (June 5–7) spotlights the need for more Spanish-speaking doctors to improve care, trust, and outcomes for Latino patients. ANAHEIM, CA, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- With over 1.9 million Californians …

Distribution channels: Conferences & Trade Fairs, Education ...
Published on June 2, 2025 - 18:04 GMT

NIEMOpen Announces New Analytical Laboratory Sub-Committee and Data Model Additions

WASHINGTON, DC, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- NIEMOpen, an open-source framework promoting seamless data sharing, is excited to announce the formation of the new Analytical Laboratory Sub-Committee and the addition of new data …

Distribution channels: Business & Economy, Companies ...
Published on June 2, 2025 - 17:27 GMT

Women Grow and Illinois Women in Cannabis Host Bloom & Bond Networking Night During Benzinga Cannabis Capital Conference

Connect with industry leaders, gain funding insights, and build lasting relationships CHICAGO, IL, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- As part of Benzinga Cannabis Capital Conference’s #InvestInHER initiative, Women Grow and …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...
Published on June 2, 2025 - 17:19 GMT

Time is running out for Connecticut legislators to enact a law against female genital mutilation

Over 2,500 women and girls in Connecticut are at risk of or have undergone female genital mutilation/ cutting. NEW YORK, NY, UNITED KINGDOM, June 2, 2025 /⁨EINPresswire.com⁩/ -- Connecticut legislators have only two days left to vote to enact …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on June 2, 2025 - 16:28 GMT

Executives Are Being Mapped Online Without Posting — New Report Exposes Digital Risks

Edge Point Group's free guide reveals how public data—real estate, fitness apps, and family tags—creates risk for high-profile individuals. WASHINGTON, DC, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- EXECUTIVES AREN’T INVISIBLE: NEW …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...
Published on June 2, 2025 - 16:19 GMT

Laveen Lasik Launches Premium Vision Correction Services in Phoenix With Advanced LASIK Technology

Offering cutting-edge LASIK procedures, Laveen Lasik brings safe, affordable vision correction solutions to the greater Phoenix community. PHOENIX, AZ, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Laveen Lasik, a modern eye care clinic …

Distribution channels: Culture, Society & Lifestyle, Education ...
Published on June 2, 2025 - 16:00 GMT

New report finds healthcare falling behind in digital experimentation, putting growth and patient access at risk

Healthcare is the slowest industry to adopt digital testing practices, limiting innovation and frustrating patients, according to 2025 research from Kameleoon. NEW YORK, NY, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- A new industry report …

Distribution channels: Healthcare & Pharmaceuticals Industry, IT Industry ...
Published on June 2, 2025 - 16:00 GMT

AST Launches Enhanced 2025 Industry Patent Purchase Program (IP3) with Group Licensing Option

AST launched its 10th annual IP3 initiative for 2025, connecting patent owners with leading technology companies for streamlined transactions. PRINCETON, NJ, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Allied Security Trust (AST), a member …

Distribution channels: Amusement, Gaming & Casino, Automotive Industry ...
Published on June 2, 2025 - 15:46 GMT

Alpas Wellness La Plata Reinforces Recovery with Comprehensive Relapse Prevention Strategies

LA PLATA, MD, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Alpas Wellness Maryland Recovery Center, a leading addiction recovery and behavioral health center in Charles County, Maryland, is placing a renewed spotlight on Relapse Prevention …

Distribution channels: Companies, Culture, Society & Lifestyle ...
Published on June 2, 2025 - 15:34 GMT

Transformation Counseling, LLC Launches Psychedelic-Assisted Therapy Services

Therapy practice now includes guided psychedelic experiences under licensed facilitation in Oregon and Colorado ST. LOUIS, MO, UNITED STATES, June 2, 2025 /⁨EINPresswire.com⁩/ -- Transformation Counseling, LLC, a therapy practice based in St. …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...